The independent source for health policy research, polling, and news.
1,161 - 1,180 of 3,889 Results
Private equity companies are the house-flippers of the investment world, and they’ve found their way into many areas of our lives — including your local gastroenterologist's office.
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
Hundreds of nurses gathered outside a Nashville courthouse to protest RaDonda Vaught’s prosecution for a medical mistake, and cheered when her probation sentence was announced.
Travel nurse contracts that were plentiful and paid the temporary nurses far more than hospital staff nurses are vanishing. Hospitals nationwide are turning their energies to recruiting full-time people.
Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications is no bargain after prices go up.
A Massachusetts health care cost watchdog agency helped block plans of the state’s largest hospital system to expand into the suburbs. Now, other states are looking at whether Massachusetts’ decade-old model of controlling health costs is worth emulating.
After a Tennessee nurse killed a patient because of a drug error, the companies behind hospital medication cabinets said they’d make the devices safer. But did they?
Dying malls have turned out to be good places to care for the living. During the pandemic, mall-to-medicine transitions accelerated, with at least 10 health systems moving in where retail has moved out.
Federal funding that paid for covid testing, treatment, and vaccines for uninsured people has run out. While some states struggle to make up the difference, California is relying on other state and local programs to continue free testing.
Colorado is requiring insurers that offer public option plans to collect demographic data on health providers, including race and sexual orientation. The aim is to connect patients with the right provider, but providers are worried about their privacy.
As Google joins Apple in adding heart rhythm sensors to wearable devices, and millions of people gain access to alerts that flag when their hearts might have skipped a beat, cardiologists are wondering what to do with all the information.
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Across Los Angeles County, few people are showing up at covid vaccination drives even though nearly 2 million residents remain unvaccinated.
A controversial proposal to grant HMO giant Kaiser Permanente a no-bid statewide Medicaid contract is headed for its first legislative hearing amid vocal opposition from a coalition of counties, competing health plans, community clinics, and a national health care labor union.
Empathy overload and compassion fatigue contribute to the mental health woes of veterinarians, who are more likely than other Americans to attempt suicide. And with 23 million families adopting pets during the pandemic, vets’ stress burden is no doubt heavier now.
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
In his State of the Union address, President Joe Biden decried these financial arrangements, which two members of the powerful House Ways and Means Committee had already asked the Government Accountability Office to investigate.
Nearly all psychiatric residential treatment centers for children in South Carolina operate as for-profit businesses — some backed by private equity — and many prioritize out-of-state kids because it’s better for the bottom line. The scramble to secure treatment for children and teenagers has become so competitive that South Carolina will spend millions more each year as of April 1 to keep out-of-state patients from flooding the state's treatment facilities.
The company awarded the state’s Medi-Cal Rx contract was taken over by another company, Centene. That left the state with a contractor it didn’t pick — one that has been accused of overbilling nine other state Medicaid programs and is now under investigation by California.
A bill one family considered paid wrongfully resurfaced, resurrecting painful memories. It’s a scenario that’s not uncommon but grievously unsettling.
© 2026 KFF